Research examining the psychological impact and health behaviors of patients undergoing germline BRCA1/2 testing described a cognitive process that follows result disclosure, where tested individuals must interpret their own cancer genetic risk in the context of their personal and/or familial cancer history [15]. The gene discussed is BRCA1; the disease is cancer.